Business Context and Reporting Period
Company: HealthSouth Corporation (Note: Input metadata referenced "Encompass Health," but the filing text identifies the registrant as HealthSouth Corporation).
Filing Type: Form 10-Q (Quarterly Report).
Reporting Period: Three and nine months ended September 30, 1999.
Operations: The Company provides outpatient and rehabilitative healthcare services through inpatient rehabilitation facilities, surgery centers, diagnostic centers, and medical centers. As of September 30, 1999, it operated nearly 2,000 locations across 50 states, the UK, and Australia.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 1999 | Nine Months Ended Sep 30, 1999 |
|---|---|---|
| Revenues | $993.3 million | $3,071.5 million |
| Net Income (Loss) | $(4.3) million | $219.6 million |
| Diluted EPS | $(0.01) | $0.52 |
| Operating Cash Flow | N/A | $475.2 million |
| Cash and Equivalents | $158.2 million | $158.2 million (Ending Balance) |
| Total Debt (Long-term + Current) | $3,060.6 million | $3,060.6 million (Ending Balance) |
| Working Capital | $1,147.7 million | $1,147.7 million (Ending Balance) |
Material Changes vs. Prior Period
- Revenue Decline (Q3): Revenues decreased 5.2% to $993.3 million compared to the prior year quarter, driven by an increased Medicare mix in inpatient services, lower same-store growth in outpatient services, and pricing pressures.
- Net Loss (Q3): The Company reported a net loss of $4.3 million for the quarter, a reversal from a $5.7 million profit in the same period in 1998. This was primarily due to a significant increase in the provision for doubtful accounts.
- Provision for Doubtful Accounts: Increased dramatically to $138.7 million (14.0% of revenue) in Q3 1999 from $24.0 million in Q3 1998. This included $117.8 million in additional reserves for accounts receivable deemed uncollectible, largely related to facilities previously subject to 1998 impairment charges.
- Year-to-Date Performance: For the nine months ended September 30, 1999, revenues increased 3.6% to $3.07 billion, while net income decreased 8.7% to $219.6 million compared to the prior year.
- Days Sales Outstanding: Increased from 81.8 days at year-end 1998 to 96.2 days at September 30, 1999, attributed to delays by payors in processing claims.
Guidance, Outlook, and Risks
- Restructuring Charges: The Company announced on September 9, 1999, an expectation to incur restructuring and other charges ranging from $250 million to $300 million during the third and fourth quarters of 1999. A component of this ($25 million to $30 million) relates to the write-off of computer hardware and software due to Year 2000 compliance issues.
- Spin-off Proposal: A previously announced plan to spin off inpatient operations into a separate public company was indefinitely tabled by the Board of Directors on September 9, 1999, due to market conditions and reimbursement system developments.
- Capital Allocation: The Company anticipates spending $200 million to $300 million on facility maintenance/expansion and $300 million to $500 million on share repurchases over the next twelve months.
- Year 2000 Risk: The "reasonably likely worst case" scenario identified is a material failure in third-party payors' systems, potentially delaying reimbursements. The Company estimates remediation costs for hardware/software at $35 million to $40 million.
- Legal Proceedings: The Company is defending against consolidated securities class action lawsuits alleging misrepresentations regarding financial condition and the impact of the Balanced Budget Act of 1997. The Company believes these claims are without merit.
Investor Verification Checklist
- Bad Debt Reserves: Verify the adequacy of the $117.8 million increase in the provision for doubtful accounts and the specific facilities involved.
- Payor Delays: Monitor the trend in days sales outstanding (currently 96.2 days) and the resolution of claims processing delays with Medicare and other payors.
- Upcoming Charges: Confirm the timing and magnitude of the anticipated $250 million to $300 million in restructuring and Year 2000 charges in Q4 1999.
- Debt Covenants: Review the impact of the Q3 loss and increased debt levels on compliance with the $1.75 billion revolving credit facility covenants.
- Legal Exposure: Track the status of the consolidated securities litigation and any potential settlement or judgment impacts.